These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2188759)

  • 1. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.
    Malinow MR
    Circulation; 1990 Jun; 81(6):2004-6. PubMed ID: 2188759
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.
    Tawakol A; Omland T; Gerhard M; Wu JT; Creager MA
    Circulation; 1997 Mar; 95(5):1119-21. PubMed ID: 9054838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine, Marfan syndrome and arteriosclerosis.
    McCully KS
    Eur Heart J; 2003 Nov; 24(22):1995-6. PubMed ID: 14613733
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.
    Kang SS; Wong PW; Malinow MR
    Annu Rev Nutr; 1992; 12():279-98. PubMed ID: 1503807
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperhomocyst(e)inemia and atherothrombosis.
    Welch GN; Upchurch G; Loscalzo J
    Ann N Y Acad Sci; 1997 Apr; 811():48-58; discussion 58-9. PubMed ID: 9186584
    [No Abstract]   [Full Text] [Related]  

  • 8. The oxidant stress of hyperhomocyst(e)inemia.
    Loscalzo J
    J Clin Invest; 1996 Jul; 98(1):5-7. PubMed ID: 8690803
    [No Abstract]   [Full Text] [Related]  

  • 9. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
    Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
    J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes and consequences of hyperhomocyst(e)inemia.
    Pietrzik K; Brönstrup A
    Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
    J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cyst(e)ine in homocyst(e)inemia.
    Malloy MH; Rassin DK; Gaull GE
    Am J Clin Nutr; 1981 Dec; 34(12):2619-21. PubMed ID: 7315764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
    Malinow MR; Kang SS; Taylor LM; Wong PW; Coull B; Inahara T; Mukerjee D; Sexton G; Upson B
    Circulation; 1989 Jun; 79(6):1180-8. PubMed ID: 2785871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine as a risk factor for arteriosclerosis.
    Kuritzky L
    Hosp Pract (1995); 1996 Mar; 31(3):37, 41. PubMed ID: 8596007
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
    Woo KS; Chook P; Lolin YI; Cheung AS; Chan LT; Sun YY; Sanderson JE; Metreweli C; Celermajer DS
    Circulation; 1997 Oct; 96(8):2542-4. PubMed ID: 9355891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.
    Ridker PM; Hennekens CH; Selhub J; Miletich JP; Malinow MR; Stampfer MJ
    Circulation; 1997 Apr; 95(7):1777-82. PubMed ID: 9107163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperhomocysteinemia: risk factor for premature atheromatosis].
    Wautrecht JC
    Rev Med Brux; 1997 Jun; 18(3):103-6. PubMed ID: 9273596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC; Oka RK; Graf EE; Schmölzer I; Upson BM; Kapoor O; Szuba A; Malinow MR; Wascher TC; Pachinger O; Cooke JP
    Circulation; 2003 Aug; 108(8):933-8. PubMed ID: 12912818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes.
    McGill JJ; Mettler G; Rosenblatt DS; Scriver CR
    Am J Med Genet; 1990 May; 36(1):45-52. PubMed ID: 2185635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Optimism in the control of atherosclerosis.
    Spaet TH
    N Engl J Med; 1974 Sep; 291(11):576-7. PubMed ID: 4211947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.